Anxiety, Depression Increased in Pancreatic Cancer Patients With Palliative Care Consult

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 15, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 15, 2024 -- Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of anxiety and depression, according to a study recently published in Healthcare.

Divya S. Subramaniam, Ph.D., M.P.H., from the Saint Louis University School of Medicine, and colleagues conducted a retrospective analysis of a sample of patients in the United States with newly diagnosed pancreatic cancer identified via electronic health record data. Subsequent diagnoses of anxiety and depression were determined, as were PC encounters, and the adjusted associations of mental health treatments with PC were quantified.

The researchers found that among the 4,029 newly diagnosed pancreatic cancer patients, the prevalence of anxiety and depression was higher for those with PC consultations (33.9 versus 22.8 percent and 36.2 versus 23.2 percent, respectively). There was variation seen in mental health service use and pharmacotherapy, with patients experiencing both anxiety and depression having the highest utilization. Age also influenced treatment patterns (adjusted odds ratio, 1.832 for younger than 55 years versus 65 to 70 years). PC consultations had no significant impact on the likelihood of documented treatment.

"Our study highlights the need for further investigation of palliative care in relation to mental health treatments and services utilization for pancreatic cancer patients," the authors write. "Furthermore, our study findings can serve as a valuable resource for health care providers, enabling them to make informed decisions regarding the implementation of palliative care."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords